Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for c…
Amends Medicare law (Title XVIII) to continue incentive payments for participation in eligible alternative payment models by updating statutory year references and adjusting the percentage amounts used to calculate those incentive payments for 2027 and 2028. Also makes conforming amendments to physician payment rules to align those year and percentage changes.
Liberals emphasize patient access and value-based benefits
Relative to its intended legislative type, this bill is a narrowly targeted substantive amendment to Medicare law that modifies specific statutory years and payment percentages for alternative payment model incentives.
Amends Medicare law (Title XVIII) to continue incentive payments for participation in eligible alternative payment models by updating statutory year references and adjusting the percentage amounts used to calculate those incentive payments for 2027 and 2028.
Also makes conforming amendments to physician payment rules to align those year and percentage changes.
Targeted, low-controversy payment change with modest fiscal effect increases chances; success depends on committee action and Senate clearance.
Relative to its intended legislative type, this bill is a narrowly targeted substantive amendment to Medicare law that modifies specific statutory years and payment percentages for alternative payment model incentives. It uses precise citations and conforming amendments to integrate with the existing statutory framework.
Liberals emphasize patient access and value-based benefits
These are examples from the analysis, not a ranked list of the most-affected groups.
Liberals emphasize patient access and value-based benefits
Likely supportive because the bill preserves and extends incentives for accountable care and value-based models that can improve care coordination.
Concerns would focus on ensuring equity, robust quality metrics, and oversight to prevent rewarding volume or corporate consolidation (speculative).
Generally favorable as a pragmatic, incremental extension to avoid sudden payment changes for Medicare APM participants.
Will want clear cost estimates, performance data, and a time-limited extension with reporting requirements.
Skeptical: may appreciate avoiding disruption to providers but worries the bill extends federal payment incentives and regulatory complexity.
Concerned about federal fiscal cost and possible favoritism toward certain provider models.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Targeted, low-controversy payment change with modest fiscal effect increases chances; success depends on committee action and Senate clearance.
The bill has not accumulated any surfaced votes yet.
Liberals emphasize patient access and value-based benefits
Targeted, low-controversy payment change with modest fiscal effect increases chances; success depends on committee action and Senate cleara…
Relative to its intended legislative type, this bill is a narrowly targeted substantive amendment to Medicare law that modifies specific statutory years and payment percentages for alternative payment model incentives.…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.